Cargando…
Deep Learning-driven research for drug discovery: Tackling Malaria
Malaria is an infectious disease that affects over 216 million people worldwide, killing over 445,000 patients annually. Due to the constant emergence of parasitic resistance to the current antimalarial drugs, the discovery of new drug candidates is a major global health priority. Aiming to make the...
Autores principales: | Neves, Bruno J., Braga, Rodolpho C., Alves, Vinicius M., Lima, Marília N. N., Cassiano, Gustavo C., Muratov, Eugene N., Costa, Fabio T. M., Andrade, Carolina Horta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048302/ https://www.ncbi.nlm.nih.gov/pubmed/32069285 http://dx.doi.org/10.1371/journal.pcbi.1007025 |
Ejemplares similares
-
QSAR-Driven Design and Discovery of Novel Compounds With Antiplasmodial and Transmission Blocking Activities
por: Lima, Marilia N. N., et al.
Publicado: (2018) -
QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery
por: Neves, Bruno J., et al.
Publicado: (2018) -
Cheminformatics-driven discovery of polymeric micelle formulations for poorly soluble drugs
por: Alves, Vinicius M., et al.
Publicado: (2019) -
STopTox: An in Silico Alternative to Animal Testing for Acute Systemic and Topical Toxicity
por: Borba, Joyce V.B., et al.
Publicado: (2022) -
Computer-Aided Discovery of New Solubility-Enhancing Drug Delivery System
por: Mizera, Mikołaj, et al.
Publicado: (2020)